Biological management of Heterodera glycines in soybean
Multi-Science Journal · 09.06.2026 · 9 (1) · 50-57
DOI: 10.33837/msj.v9i1.1742 ↗Kurz gefasst
Fachartikel in der Zeitschrift Multi-Science Journal, online erschienen am 09.06.2026. Verfasst von Diego Alves Silva und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Soybean (Glycine max (L.) Merrill) is one of Brazil's most important agricultural crops, playing a key economic and strategic role in agribusiness. However, its productivity is continually threatened by plant-parasitic nematodes, especially Heterodera glycines, which cause significant yield losses. Given the limitations of chemical control and the growing demand for sustainable practices, bioinputs have emerged as a viable alternative for managing this pathogen. This study reviews biological control strategies against H. glycines using beneficial microorganisms such as fungi and bacteria. The findings show that agents such as Purpureocillium lilacinum, Pochonia chlamydosporia, Bacillus spp., and Trichoderma spp. are effective in suppressing nematode populations, promoting plant growth, and improving soil health. The integration of these bioinputs with other practices, including the use of resistant cultivars and crop rotation, is essential for the success of integrated pest management in soybean cultivation.
Zitieren
APA
Silva, D. A., Moreira, B. R., & Neto, J. F. B. (2026). Biological management of Heterodera glycines in soybean. Multi-Science Journal, 9(1), 50-57. https://doi.org/10.33837/msj.v9i1.1742
Vancouver
Silva DA, Moreira BR, Neto JFB. Biological management of Heterodera glycines in soybean. Multi-Science Journal. 2026;9(1):50-57. doi:10.33837/msj.v9i1.1742
BibTeX
@article{Silva2026,
author = {Silva, Diego Alves and Moreira, Bruna Rodrigues and Neto, José Feliciano Bernardes},
title = {Biological management of Heterodera glycines in soybean},
journal = {Multi-Science Journal},
year = {2026},
volume = {9},
number = {1},
pages = {50--57},
doi = {10.33837/msj.v9i1.1742}
}
EUVIMED